Nasrin Gholami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nasrin Gholami has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Amirreza Khalaji
Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4 shared publications - Ali Esfahani
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications Alireza Ghaffari
2 shared publicationsHossein Ghasemi Moghaddam
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications- Mohammad Naghavi-Behzad
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
2 shared publications - Reza Piri
Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark
2 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73536
Presumed Primary Cardiac Angiosarcoma With Atrioventricular Groove Rupture and Right Coronary Artery Compromise: A Case Report and Literature Review
Primary cardiac angiosarcoma should be considered in patients with hemorrhagic pericardial effusion and a right‐sided infiltrative cardiac mass. Atrioventricular‐groove involvement may cause rupture and right coronary artery compromise, requiring multimodality imaging and emergency salvage surgery; early multidisciplinary planning is essential because complete resection may be impossible.
- 18 September 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73536
Open AccessPresumed Primary Cardiac Angiosarcoma With Atrioventricular Groove Rupture and Right Coronary Artery Compromise: A Case Report and Literature Review
Primary cardiac angiosarcoma should be considered in patients with hemorrhagic pericardial effusion and a right‐sided infiltrative cardiac mass. Atrioventricular‐groove involvement may cause rupture and right coronary artery compromise, requiring multimodality imaging and emergency salvage surgery; early multidisciplinary planning is essential because complete resection may be impossible.
- Open Access
- 8 August 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (158) , 237-240
Septic Arthritis Caused by Klebsiella pneumoniae in a Patient with B-cell Acute Lymphoblastic Leukemia: A Case Report
This case report describes a 53-year-old female with newly diagnosed B-cell acute lymphoblastic leukemia (ALL) who developed septic arthritis due to Klebsiella pneumoniae during induction chemotherapy with a modified CALGB protocol. The diagnosis was challenging, requiring multiple imaging modalities (ultrasound, MRI, and PET scan), and was ultimately confirmed via synovial fluid culture ...
- 8 August 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (158) , 237-240
Open AccessSeptic Arthritis Caused by Klebsiella pneumoniae in a Patient with B-cell Acute Lymphoblastic Leukemia: A Case Report
This case report describes a 53-year-old female with newly diagnosed B-cell acute lymphoblastic leukemia (ALL) who developed septic arthritis due to Klebsiella pneumoniae during induction chemotherapy with a modified CALGB protocol. The diagnosis was challenging, requiring multiple imaging modalities (ultrasound, MRI, and PET scan), and was ultimately confirmed via synovial fluid culture ...
- Open Access
- 18 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Author Correction: Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
- 18 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Open AccessAuthor Correction: Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
- Open Access
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
Background This study investigated the association between prostaglandins, vitamin D levels, and their potential role in acute myeloid leukemia (AML). Previous research has shown prostaglandins’ stimulatory effects and vitamin D’s inhibitory effects in various malignancies. Methods This cross-sectional study evaluated 54 AML patients at Shahid Ghazi Center of Imam Reza Hospital in Tabriz. Prostaglandin E2 (PGE2), Cyclooxygenase-2 (COX-2), and serum vitamin D levels, as well as gene expression of 5-hydroxyprostaglandin dehydrogenase (15-PGDH), COX-2, PGE2 synthase, and vitamin D receptor (VDR), were measured. Relationships were assessed between vitamin D levels, COX-2 and PGE2 expression, serum levels, and treatment outcomes. Results Median serum vitamin D level was 18.25 ng/mL (range: 4.00-72.70). There was no significant association between serum vitamin D levels and expression or serum levels of COX-2, PGE2 synthase, and 15-PGDH. VDR gene expression and serum levels showed significant direct correlations with PGE2 and COX-2 gene expression and serum concentrations and inverse correlations with 15-PGDH expression (P < 0.05). No statistically significant correlation was observed between vitamin D status, PGE2, COX-2, and 15-PGDH with treatment outcomes. Conclusion This study on AML patients showed no significant correlation between vitamin D levels and COX-2, PGE2 synthase, or 15-PGDH. VDR expression correlated positively with PGE2 and COX-2 but negatively with 15-PGDH. No associations were found between these factors and therapy outcomes.
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessSerum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
Background This study investigated the association between prostaglandins, vitamin D levels, and their potential role in acute myeloid leukemia (AML). Previous research has shown prostaglandins’ stimulatory effects and vitamin D’s inhibitory effects in various malignancies. Methods This cross-sectional study evaluated 54 AML patients at Shahid Ghazi Center of Imam Reza Hospital in Tabriz. Prostaglandin E2 (PGE2), Cyclooxygenase-2 (COX-2), and serum vitamin D levels, as well as gene expression of 5-hydroxyprostaglandin dehydrogenase (15-PGDH), COX-2, PGE2 synthase, and vitamin D receptor (VDR), were measured. Relationships were assessed between vitamin D levels, COX-2 and PGE2 expression, serum levels, and treatment outcomes. Results Median serum vitamin D level was 18.25 ng/mL (range: 4.00-72.70). There was no significant association between serum vitamin D levels and expression or serum levels of COX-2, PGE2 synthase, and 15-PGDH. VDR gene expression and serum levels showed significant direct correlations with PGE2 and COX-2 gene expression and serum concentrations and inverse correlations with 15-PGDH expression (P < 0.05). No statistically significant correlation was observed between vitamin D status, PGE2, COX-2, and 15-PGDH with treatment outcomes. Conclusion This study on AML patients showed no significant correlation between vitamin D levels and COX-2, PGE2 synthase, or 15-PGDH. VDR expression correlated positively with PGE2 and COX-2 but negatively with 15-PGDH. No associations were found between these factors and therapy outcomes.
- Open Access
- 20 February 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (2) , e8543
Acute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report
Key Clinical Message: Novel and rare chromosomal aberrations in AML are important to understand, particularly if associated with tumorigenesis and how they contribute to prognostic risk. It is important that acute leukemia be treated right away. Herein, novel (x; 3) (q24; p13) is described. Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. It is the most common type of acute leukemia in adults. This type of cancer usually gets worse quickly if it is not treated. Here, we report an unusual case of AML with an unreported translocation associated with AML.
- 20 February 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (2) , e8543
Open AccessAcute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report
Key Clinical Message: Novel and rare chromosomal aberrations in AML are important to understand, particularly if associated with tumorigenesis and how they contribute to prognostic risk. It is important that acute leukemia be treated right away. Herein, novel (x; 3) (q24; p13) is described. Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. It is the most common type of acute leukemia in adults. This type of cancer usually gets worse quickly if it is not treated. Here, we report an unusual case of AML with an unreported translocation associated with AML.
- Open Access
- 8 January 2024
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 2024, 1-5
Correlation between PD-L1 Expression, Clinicopathological Factors, and Metastasis Risk in Colorectal Cancer Patients
This study investigated the correlation between PD-L1 expression, metastasis, and survival in colorectal cancer (CRC) patients. PD-L1 expression was not significantly associated with overall survival, disease-free survival, or mortality rate. However, a significant difference was observed between PD-L1 positive and negative patients regarding the presence of metastasis, which was higher in the PD-L1 positive group. These findings suggest that PD-L1 expression may impact metastasis in CRC patients but not overall survival.
- 8 January 2024
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 2024, 1-5
Open AccessCorrelation between PD-L1 Expression, Clinicopathological Factors, and Metastasis Risk in Colorectal Cancer Patients
This study investigated the correlation between PD-L1 expression, metastasis, and survival in colorectal cancer (CRC) patients. PD-L1 expression was not significantly associated with overall survival, disease-free survival, or mortality rate. However, a significant difference was observed between PD-L1 positive and negative patients regarding the presence of metastasis, which was higher in the PD-L1 positive group. These findings suggest that PD-L1 expression may impact metastasis in CRC patients but not overall survival.
- Open Access
- 1 July 2021
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 31 (3)
Isolated hyperbilirubinemia as the manifestation of acute liver failure in a patient with acute myelogenous leukemia and COVID-19 infection
Acute liver failure is a rare but catastrophic syndrome. Liver function tests usually reveal cholestatic or hepatocellular pattern, but in this case, we report a previously undescribed manifestation of this condition as isolated hyperbilirubinemia. Our patient was a 50 years old male who was diagnosed with acute myelogenous leukemia (AML(M4)). The patient had no history of liver disease and had normal liver function tests at the time of admission. After chemotherapy treatment, the patient developed signs of acute liver failure and had a rapid demise. After further investigations, we found two possible causes. Firstly, liver involvement of acute myelogenous leukemia (AML) which after induction chemotherapy is a rare condition and has high mortality rates despite treatment. Secondly, acute liver injury due to COVID-19 infection.
- 1 July 2021
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 31 (3)
Open AccessIsolated hyperbilirubinemia as the manifestation of acute liver failure in a patient with acute myelogenous leukemia and COVID-19 infection
Acute liver failure is a rare but catastrophic syndrome. Liver function tests usually reveal cholestatic or hepatocellular pattern, but in this case, we report a previously undescribed manifestation of this condition as isolated hyperbilirubinemia. Our patient was a 50 years old male who was diagnosed with acute myelogenous leukemia (AML(M4)). The patient had no history of liver disease and had normal liver function tests at the time of admission. After chemotherapy treatment, the patient developed signs of acute liver failure and had a rapid demise. After further investigations, we found two possible causes. Firstly, liver involvement of acute myelogenous leukemia (AML) which after induction chemotherapy is a rare condition and has high mortality rates despite treatment. Secondly, acute liver injury due to COVID-19 infection.
- 16 January 2021
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 9 (1) , 2
Complete resolve of primary cardiac sarcoma by chemotherapy: A case report
Primary cardiac tumors (PCT) are rare with high mortality rate and low survival. There are several treatment approaches in the PCT management. Complete surgical resection is the main base of treatment and there is disagreement on adjuvant chemotherapy or radiotherapy after surgical resection. In this case report, complete remission of the relapsed non-metastatic cardiac synovial sarcoma was observed after salvage chemotherapy and complete surgical resection.
- 16 January 2021
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 9 (1) , 2
Complete resolve of primary cardiac sarcoma by chemotherapy: A case report
Primary cardiac tumors (PCT) are rare with high mortality rate and low survival. There are several treatment approaches in the PCT management. Complete surgical resection is the main base of treatment and there is disagreement on adjuvant chemotherapy or radiotherapy after surgical resection. In this case report, complete remission of the relapsed non-metastatic cardiac synovial sarcoma was observed after salvage chemotherapy and complete surgical resection.
- Open Access
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7567-7573
Complications and Carcinogenic Effects of Mustard Gas - a Systematic Review and Meta-Analysis in Iran
Catastrophic effects of mustard gas as a chemical warfare agent have always been a major problem for those exposed to this agent. In this meta-analysis it was tried to evaluate carcinogenesis, ocular, cutaneous and respiratory complications of mustard gas exposure among Iranians who had been exposed to this agent during the Iran-Iraq war. In this meta-analysis, the required data were collected using keywords "mustard gas", "sulfur mustard", "cancer", "neoplasm", "respiratory complications", "ocular complications" , "lung disease", "chronic complication", "eye", "skin", "cutaneous complication", "carcinogenesis" and their combination with keywords "Iran", "Iranian", "prevalence", "mortality" and their Farsi equivalent terms from the databases of SID, Iranmedex, Magiran, Pubmed, Science Direct, Google Search engine, Gray Literature and Reference of References. To determine the prevalence of each complication and perform meta-analysis, CMA: 2 (Comprehensive Meta-Analysis) software with a randomized model was used. Of the 542 articles found, 7 national articles, consistent with the aims of this study were selected. Meta- analysis of seven papers revealed that cancer risk, especially cancer of the respiratory system was elevated, so that the relative risk (RR) of cancer role of mustard gas was inconsistent from 2/1 to 4 in this survey. Also prevalence of delayed skin disorders due to sulfur mustard was 94.6%, pulmonary complications 94.5% and ocular complications 89.9%. The incidence of various cancers in victims exposed to mustard gas was 1.7% worldwide where the rate was 2.2% in Iranian victims of the Iraq-Iran war. Based on present study the prevalence of delayed mustard gas related cutaneous, pulmonary and ocular complications is above 90% and risk of carcinogenesis is higher in comparison to worldwide statistics. This may suggest need for long-term and persistent follow-up and rehabilitation procedures for populations exposed to this agent.
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7567-7573
Open AccessComplications and Carcinogenic Effects of Mustard Gas - a Systematic Review and Meta-Analysis in Iran
Catastrophic effects of mustard gas as a chemical warfare agent have always been a major problem for those exposed to this agent. In this meta-analysis it was tried to evaluate carcinogenesis, ocular, cutaneous and respiratory complications of mustard gas exposure among Iranians who had been exposed to this agent during the Iran-Iraq war. In this meta-analysis, the required data were collected using keywords "mustard gas", "sulfur mustard", "cancer", "neoplasm", "respiratory complications", "ocular complications" , "lung disease", "chronic complication", "eye", "skin", "cutaneous complication", "carcinogenesis" and their combination with keywords "Iran", "Iranian", "prevalence", "mortality" and their Farsi equivalent terms from the databases of SID, Iranmedex, Magiran, Pubmed, Science Direct, Google Search engine, Gray Literature and Reference of References. To determine the prevalence of each complication and perform meta-analysis, CMA: 2 (Comprehensive Meta-Analysis) software with a randomized model was used. Of the 542 articles found, 7 national articles, consistent with the aims of this study were selected. Meta- analysis of seven papers revealed that cancer risk, especially cancer of the respiratory system was elevated, so that the relative risk (RR) of cancer role of mustard gas was inconsistent from 2/1 to 4 in this survey. Also prevalence of delayed skin disorders due to sulfur mustard was 94.6%, pulmonary complications 94.5% and ocular complications 89.9%. The incidence of various cancers in victims exposed to mustard gas was 1.7% worldwide where the rate was 2.2% in Iranian victims of the Iraq-Iran war. Based on present study the prevalence of delayed mustard gas related cutaneous, pulmonary and ocular complications is above 90% and risk of carcinogenesis is higher in comparison to worldwide statistics. This may suggest need for long-term and persistent follow-up and rehabilitation procedures for populations exposed to this agent.
- Open Access
- 4 November 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (16) , 6997-7002
Ki-67/MIB-1 as a Prognostic Marker in Cervical Cancer - a Systematic Review with Meta-Analysis
In cervical cancer patients it has been reported that there in a significant Ki-67/MIB-1 expression is correlated with survival in cervical cancer patients. However, the prognostic value is still not well understood. In the present meta-analysis the prognostic value of Ki-67/MIB-1 with regard to overall survival (OS) and disease-free survival (DFS) in cervical cancer was investigated. The databases of PubMed, ISI Web of Science, Cochrane Central Register of Controlled Trials, EMBASE, Science Direct and Wiley Online Library were used to identify appropriate literature. In order to explore the relationship between Ki-67/ MIB-1 and cervical cancer, we have included 13 studies covering 894 patients in the current meta-analysis. The effect of Ki-67/MIB-1 on OS for pooled random effects HR estimate was 1.63 (95%confidence interval (CI) 1.09- 2.45; P0.05) and the subgroup analysis indicated Ki-67/MIB1 was associated with DFS (HR=3.67, 95%CI 2.65-5.09) in Asians. According to this meta-analysis, Ki-67/MIB-1 has prognostic value for OS in patients suffering from cervical cancer. For better evaluation of the prognostic role of Ki-67/MIB-1 on DFS, studies with larger numbers of patients are needed to validate present findings in the future.
- 4 November 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (16) , 6997-7002
Open AccessKi-67/MIB-1 as a Prognostic Marker in Cervical Cancer - a Systematic Review with Meta-Analysis
In cervical cancer patients it has been reported that there in a significant Ki-67/MIB-1 expression is correlated with survival in cervical cancer patients. However, the prognostic value is still not well understood. In the present meta-analysis the prognostic value of Ki-67/MIB-1 with regard to overall survival (OS) and disease-free survival (DFS) in cervical cancer was investigated. The databases of PubMed, ISI Web of Science, Cochrane Central Register of Controlled Trials, EMBASE, Science Direct and Wiley Online Library were used to identify appropriate literature. In order to explore the relationship between Ki-67/ MIB-1 and cervical cancer, we have included 13 studies covering 894 patients in the current meta-analysis. The effect of Ki-67/MIB-1 on OS for pooled random effects HR estimate was 1.63 (95%confidence interval (CI) 1.09- 2.45; P0.05) and the subgroup analysis indicated Ki-67/MIB1 was associated with DFS (HR=3.67, 95%CI 2.65-5.09) in Asians. According to this meta-analysis, Ki-67/MIB-1 has prognostic value for OS in patients suffering from cervical cancer. For better evaluation of the prognostic role of Ki-67/MIB-1 on DFS, studies with larger numbers of patients are needed to validate present findings in the future.